Consolidated Statements of Equity (Unaudited) - USD ($) $ in Millions	Total	COMMON STOCK	ADDITIONAL PAID-IN CAPITAL	RETAINED EARNINGS	ACCUMULATED OTHER COMPREHENSIVE LOSS	TREASURY SHARES	NON-CONTROLLING INTERESTS
Balance, beginning of period at Dec. 31, 2021		$ 561	$ 1,112	$ 18,389	$ (4,575)	$ (4,478)	$ 213
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in accrued stock compensation costs			(140)
Issuance of shares under stock compensation plans and employee stock purchase plans			72			149
Purchase of non-controlling interest			0
Net income attributable to the Company	$ 2,064			2,038			26
Dividend equivalents declared				(7)
Dividends declared				(540)
Other comprehensive income (loss), net of tax	(788)				(788)
Purchase of treasury shares	(1,100)					(1,100)
Net non-controlling interests acquired							0
Distributions and other changes							(15)
Balance, end of period at Jun. 30, 2022	$ 10,917	561	1,044	19,880	(5,363)	(5,429)	224
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared per share (in dollars per share)	$ 1.07
Balance, beginning of period at Mar. 31, 2022		561	1,026	18,916	(4,679)	(4,887)	219
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in accrued stock compensation costs			5
Issuance of shares under stock compensation plans and employee stock purchase plans			13			58
Purchase of non-controlling interest			0
Net income attributable to the Company	$ 978			967			11
Dividend equivalents declared				(3)
Dividends declared				0
Other comprehensive income (loss), net of tax	(684)				(684)
Purchase of treasury shares						(600)
Net non-controlling interests acquired							0
Distributions and other changes							(6)
Balance, end of period at Jun. 30, 2022	$ 10,917	561	1,044	19,880	(5,363)	(5,429)	224
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared per share (in dollars per share)	$ 0.535
Balance, beginning of period at Dec. 31, 2022	$ 10,749	561	1,179	20,301	(5,314)	(6,207)	229
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in accrued stock compensation costs			(101)
Issuance of shares under stock compensation plans and employee stock purchase plans			66			208
Purchase of non-controlling interest			(70)
Net income attributable to the Company	2,299			2,270			29
Dividend equivalents declared				(8)
Dividends declared				(583)
Other comprehensive income (loss), net of tax	259				259
Purchase of treasury shares	(600)					(600)
Net non-controlling interests acquired							(69)
Distributions and other changes							(11)
Balance, end of period at Jun. 30, 2023	$ 12,139	561	1,074	21,980	(5,055)	(6,599)	178
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared per share (in dollars per share)	$ 1.18
Balance, beginning of period at Mar. 31, 2023		561	1,064	20,949	(5,234)	(6,387)	243
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in accrued stock compensation costs			89
Issuance of shares under stock compensation plans and employee stock purchase plans			(9)			88
Purchase of non-controlling interest			(70)
Net income attributable to the Company	$ 1,047			1,035			12
Dividend equivalents declared				(4)
Dividends declared				0
Other comprehensive income (loss), net of tax	179				179
Purchase of treasury shares						(300)
Net non-controlling interests acquired							(69)
Distributions and other changes							(8)
Balance, end of period at Jun. 30, 2023	$ 12,139	$ 561	$ 1,074	$ 21,980	$ (5,055)	$ (6,599)	$ 178
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared per share (in dollars per share)	$ 0